Curcumin for Reducing Inflammation in Patients With Solid Tumors
Curcumin for Reducing Inflammation in Patients With Solid Tumors
A randomized double-blind placebo-controlled trial by Panahi and colleagues, published in Phytotherapy Research in 2014, explored whether bioavailability-enhanced curcuminoids could help reduce inflammation and improve quality of life in patients with solid tumors. The study included adults undergoing standard cancer treatment who continued to experience high levels of systemic inflammation—a common factor linked to fatigue, pain, and overall reduced wellbeing. Participants were randomly assigned to receive either curcuminoids or placebo, allowing for a clear comparison of outcomes.
The intervention consisted of a twice-daily curcuminoid supplement formulated for improved absorption, addressing one of the main limitations of traditional curcumin products. The control group received a matching placebo. Both groups continued their usual oncology care throughout the study. Researchers measured inflammatory markers such as C-reactive protein (CRP) in addition to patient-reported outcomes, including physical comfort, fatigue, and overall quality of life.
Results showed that patients taking the curcuminoid supplement experienced significant reductions in CRP and other inflammatory markers compared to placebo. These biochemical improvements were accompanied by better self-reported quality of life, including improvements in fatigue, mood, and general wellbeing. Importantly, the supplement was well tolerated, and no serious adverse events were reported, supporting the safety of curcuminoids as an adjunct therapy.
For patients seeking supportive, evidence-based natural options, this study suggests that highly bioavailable curcumin may help reduce systemic inflammation and improve overall quality of life during cancer care.
Reference:
Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. Phytother Res. 2014 Oct;28(10):1461-7. doi: 10.1002/ptr.5149. Epub 2014 Mar 19. PMID: 24648302.
